RE: RE: RE: News Out! Some might not like the dilution.
However, this also might mean less dilution in Newco and NantPro, and knowing the potential of both, it might be better in a global view.
Now, let's start the phase I on PBI-4050 to see what this can have as a potential.
And also, if another billionnaire in the pharma industry is ready to pay a premium for the equity, this might sound a bell on the real value of the comapny.
One sure thing, the balance sheet will be clean after this if the regulatory approval are give.